Hansen Medical (NSDQ:HNSN) said today it launched the Magellan Mobility package for its Magellan robotic system, shipping the 1st unit to the Miami Cardiac & Vascular Institute in Florida.
The Magellan Mobility package allows the Magellan robotic arm to be shared among different procedure rooms equipped to support it, allowing it to be used in many different specialized settings, the Mountain View, Calif.-based company said.
“Congratulations to MCVI on being the first hospital in the U.S. to adopt the Magellan Mobility concept. By incorporating Magellan Mobility capabilities into their state-of-the-art labs, we expect greater utilization of the Magellan Robotic System and more patients benefitting from advanced intravascular robotic therapies,” CEO Cary Vance said in a press release.
The Magellan system drives Magellan robotic catheters and guide wires in minimally-invasive endovascular procedures and can be controlled remotely to allow for the use of interventional fluoroscopy during the procedures without risking radiation exposure, the company said.
Last week, Hansen said it inked an agreement with AB Medica Sagl to operate as the exclusive distributor of its Magellan robotic system in Switzerland.
AB Medica Sagl also serves as the company’s exclusive distributor in Italy, California-based Hansen Medical said. Hansen Medical shipped one of its Magellan robotic systems to AB Medica as part of the agreement, the company said.
Last month, Hansen Medical pulled the trigger on a reverse 10-for-1 stock split in which HNSN shareholders received 1 share for every 10 they owned.
The reverse split went into effect Sept. 22, according to a regulatory filing, sending HNSN shares down -13% to $4.35 apiece.